Evaluation of Quality of Life and Its Influencing Factors After VA-ECMO in Refractory Cardiac Arrest Based on SF-36 Score : A Grenoble Cohort Study From 2006 Through 2018
AQUA
2 other identifiers
observational
75
1 country
1
Brief Summary
If the ExtraCorporeal Membrane Oxygenation (ECMO) improves survival in the management of refractory cardiac arrest (RCA), this technique is still an invasive technique, not devoid of complications and requiring intensive care that can have serious consequences for patients. If the studies so far show an acceptable quality of life post ECMO in refractory cardiac arrest, the study looks about the quality of life of our patients in Grenoble who survived a refractory cardiac arrest between 2006 and 2018 at the hospital university Grenoble Alps and the factors influencing this quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 13, 2020
CompletedStudy Start
First participant enrolled
October 16, 2020
CompletedFirst Posted
Study publicly available on registry
October 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2021
CompletedApril 30, 2021
December 1, 2020
3 months
October 13, 2020
April 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Global quality of life score
Items from the SF36 (Short Form 36) survey
Through study completion, an average of 3 months
Secondary Outcomes (4)
Live patients characteristics description
Through study completion, an average of 3 months
Vital status
Through study completion, an average of 3 months
Quality of life score related at live patients characteristics description
Through study completion, an average of 3 months
Quality of life score comparison
Through study completion, an average of 3 months
Study Arms (2)
Live patients admitted for Refractory Cardiac Arrest with ECMO
Live patients quality of life admitted for Refractory Cardiac Arrest without ECMO
Interventions
SF36 questionnaire via telephone interview
Eligibility Criteria
monocentric study based on clinical data and quality of life assessement, Retrospective step : * Clinical data collection for live patients admissed for Refractory Cardiac Arrest with ECMO from january 2006 through december 2018, * Clinical data collection for live patients admissed for Refractory Cardiac Arrest without ECMO from january 2015 through december 2018, Prospective step: * Quality of life assessment via telephone interview based on SF36 questionnaire performed for live patients admissed for Refractory Cardiac Arrest with ECMO from january 2006 through december 2018 * Quality of life assessment via telephone interview based on SF36 questionnaire performed for live patients admissed for Refractory Cardiac Arrest without ECMO from january 2015 through december 2018
You may qualify if:
- Adult \>18 years
- Admission to intensive care unit after a Refractory Cardiac Arrest
- Hemodynamic instability after resumption of spontaneous cardiac activity.
- Non-opposition of the patient or his relatives
- Admission to intensive care unit From 2006 Through 2018
You may not qualify if:
- ECMO for hypothermia or drug intoxication.
- Comorbidity contraindicated the ECMO
- Patients dead before hospital discharge
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Grenoble Alpes
Grenoble, 38043, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2020
First Posted
October 26, 2020
Study Start
October 16, 2020
Primary Completion
January 15, 2021
Study Completion
April 27, 2021
Last Updated
April 30, 2021
Record last verified: 2020-12